Eric dEsparbes - Aug 15, 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIOR)

Role
Chief Financial Officer
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
Stock symbol
BIOR
Transactions as of
Aug 15, 2023
Transactions value $
-$125,669
Form type
4
Date filed
8/17/2023, 05:22 PM
Previous filing
May 17, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability -$126K -40K -40.41% $3.14 59K Aug 15, 2023 Direct F1
transaction BIOR Common Stock Award $0 +220K +372.21% $0.00 279K Aug 15, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.
F2 Consists of 219,650 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer.